<DOC>
	<DOC>NCT01950299</DOC>
	<brief_summary>VCU-ART3 is a double-blind randomized clinical trial of anakinra high dose vs anakinra standard dose vs placebo in patients with ST-segment elevation myocardial infarction (STEMI) measuring the effects on the acute rise and fall of the plasma C reactive protein levels during the first 14 days.</brief_summary>
	<brief_title>Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)</brief_title>
	<detailed_description>VCU-ART3 is a double-blind randomized clinical trial of anakinra high dose vs anakinra standard dose vs placebo in patients with ST-segment elevation myocardial infarction (STEMI) measuring the effects on the acute rise and fall of the plasma C reactive protein levels during the first 14 days</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>INCLUSION CRITERIA: In order to be eligible for this study, patients must meet ALL the 3 Inclusion criteria and NONE of the Exclusion criteria. 1. Acute STEMI defined as chest pain (or equivalent) with an onset within 12 hours and ECG evidence of ST segment elevation (&gt;1 mm) in 2 or more anatomically contiguous leads that is new or presumably new 2. Planned or completed coronary angiogram for potential intervention 3. Age&gt;21 EXCLUSION CRITERIA: Inability to give informed consent Pregnancy Preexisting congestive heart failure (American Heart Association/American College of Cardiology class CD, New York Heart Association IIIIV) Preexisting severe left ventricular dysfunction (EF&lt;20%) Preexisting severe valvular heart disease Active infections (acute or chronic) excluding Hepatitis C Virus (HCV)+ with undetectable RNA Recent (&lt;14 days) or active use of antiinflammatory drugs (not including nonsteroidal antiinflammatory drugs [NSAIDs] or corticosteroids used for IV dye allergy only) Chronic inflammatory disease (including but not limited to rheumatoid arthritis, systemic lupus erythematosus) Active malignancy (or prior malignancy within the past 10 years) excluding carcinoma in situ [any organ] and nonmelanoma skin cancer Anticipated need for cardiac surgery Neutropenia (absolute neutrophil count&lt;1,800/mm3) Need for vaccination or desensitization that cannot be postponed for 14 days</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>